9 Meters Biopharma Inc (NMTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 12,788 | 10,741 | 8,716 | 11,195 | 11,364 |
| Operating Income | -12,788 | -10,741 | -8,716 | -11,195 | -11,364 |
| Interest Expense | 753 | 1,820 | 847 | 0 | 0 |
| Other Income | -328 | 631 | 209 | 65 | 13 |
| Pre-tax Income | -13,869 | -11,930 | -9,355 | -11,130 | -11,352 |
| Net Income Continuous | -13,869 | -11,930 | -9,355 | -11,130 | -11,352 |
| Net Income | $-13,869 | $-11,930 | $-9,355 | $-11,130 | $-11,352 |
| EPS Basic Total Ops | -1.02 | -0.98 | -0.72 | -0.80 | -0.88 |
| EPS Basic Continuous Ops | -1.02 | -0.92 | -0.72 | -0.86 | -0.88 |
| EPS Diluted Total Ops | -1.02 | -0.98 | -0.72 | -0.80 | -0.88 |
| EPS Diluted Continuous Ops | -1.02 | -0.92 | -0.72 | -0.86 | -0.88 |
| EPS Diluted Before Non-Recurring Items | -1.02 | -0.92 | -0.72 | -0.80 | -0.80 |
| EBITDA(a) | $-12,207 | $-9,408 | $-8,214 | $-11,193 | $-11,363 |